340 related articles for article (PubMed ID: 22403493)
1. The role of optical coherence tomography in coronary intervention.
Terashima M; Kaneda H; Suzuki T
Korean J Intern Med; 2012 Mar; 27(1):1-12. PubMed ID: 22403493
[TBL] [Abstract][Full Text] [Related]
2. Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions.
Choi W; Chae IH; Park JJ; Kim SH; Kang SH; Oh IY; Yoon CH; Cho YS; Youn TJ; Choi DJ
Korean J Intern Med; 2019 Jul; 34(4):819-829. PubMed ID: 29961306
[TBL] [Abstract][Full Text] [Related]
3. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
[TBL] [Abstract][Full Text] [Related]
4. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
5. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
6. INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.
Burzotta F; Brancati MF; Trani C; Porto I; Tommasino A; De Maria G; Niccoli G; Leone AM; Coluccia V; Schiavoni G; Crea F
Trials; 2012 May; 13():55. PubMed ID: 22559260
[TBL] [Abstract][Full Text] [Related]
7. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
8. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
[TBL] [Abstract][Full Text] [Related]
9. Incidence, predictors, morphological characteristics, and clinical outcomes of stent edge dissections detected by optical coherence tomography.
Chamié D; Bezerra HG; Attizzani GF; Yamamoto H; Kanaya T; Stefano GT; Fujino Y; Mehanna E; Wang W; Abdul-Aziz A; Dias M; Simon DI; Costa MA
JACC Cardiovasc Interv; 2013 Aug; 6(8):800-13. PubMed ID: 23871510
[TBL] [Abstract][Full Text] [Related]
10. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
[TBL] [Abstract][Full Text] [Related]
12. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
[TBL] [Abstract][Full Text] [Related]
13. In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation.
Suzuki Y; Ikeno F; Koizumi T; Tio F; Yeung AC; Yock PG; Fitzgerald PJ; Fearon WF
JACC Cardiovasc Interv; 2008 Apr; 1(2):168-73. PubMed ID: 19463295
[TBL] [Abstract][Full Text] [Related]
14. Frequency-domain optical coherence tomography assessment of unprotected left main coronary artery disease-a comparison with intravascular ultrasound.
Fujino Y; Bezerra HG; Attizzani GF; Wang W; Yamamoto H; Chamié D; Kanaya T; Mehanna E; Tahara S; Nakamura S; Costa MA
Catheter Cardiovasc Interv; 2013 Sep; 82(3):E173-83. PubMed ID: 23359350
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention).
Maehara A; Ben-Yehuda O; Ali Z; Wijns W; Bezerra HG; Shite J; Généreux P; Nichols M; Jenkins P; Witzenbichler B; Mintz GS; Stone GW
JACC Cardiovasc Interv; 2015 Nov; 8(13):1704-14. PubMed ID: 26585621
[TBL] [Abstract][Full Text] [Related]
16. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
17. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.
Puri R; Otaegui I; Sabaté M; Serra-Peñaranda A; Puigfel M; Perez de Prado A; Nombela-Franco L; de la Torre Hernandez JM; Ortas Nadal R; Iniguez-Romo A; Jiménez G; Fernandez-Vazquez F; Cuellas-Ramon C; Gonzalo N; Alfonso Jiménez Diaz V; Duocastella L; Molina M; Amoros M; Perez I; Barria Perez A; Pelletier Beaumont E; Nicholls SJ; Garcia Del Blanco B; Rodés-Cabau J
Catheter Cardiovasc Interv; 2018 Feb; 91(3):435-443. PubMed ID: 28707379
[TBL] [Abstract][Full Text] [Related]
18. Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography.
Chen BX; Ma FY; Luo W; Ruan JH; Xie WL; Zhao XZ; Sun SH; Guo XM; Wang F; Tian T; Chu XW
Heart; 2008 May; 94(5):566-70. PubMed ID: 17923466
[TBL] [Abstract][Full Text] [Related]
19. Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis.
Alfonso F; Dutary J; Paulo M; Gonzalo N; Pérez-Vizcayno MJ; Jiménez-Quevedo P; Escaned J; Bañuelos C; Hernández R; Macaya C
Heart; 2012 Aug; 98(16):1213-20. PubMed ID: 22826559
[TBL] [Abstract][Full Text] [Related]
20. Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography.
Choi HH; Kim JS; Yoon DH; Hong KS; Kim TH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2012 Mar; 28(3):491-7. PubMed ID: 21442265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
